Pages
- Home
- ADHD resources developed by Takeda
- Burden of ADHD
- Assessment & diagnosis
- Disease management
- Meetings & events
- On-demand events
- Webinar: Adult ADHD and comorbid borderline personality disorder webinar
- Webinar: Adult ADHD and comorbid substance-use disorder
- Webinar: Neurobiology of ADHD
- Webinar: Adult ADHD and comorbid anxiety disorders webinar
- Webinar: Adult ADHD and comorbid major depressive disorder webinar
- Webinar: Adult ADHD and comorbid bipolar disorder webinar
- ADHD Institute meetings
- Week 1 ‒ ADHD and comorbid mental health conditions across the lifespan
- Week 2 ‒ ADHD and comorbid mental health conditions across the lifespan
- Week 3 ‒ ADHD and comorbid mental health conditions across the lifespan
- Week 4 ‒ ADHD and comorbid mental health conditions across the lifespan
- Day 1 ‒ Advancing the management of ADHD across the lifespan
- Day 2 ‒ Advancing the management of ADHD across the lifespan
- A selection of clinical seminars – advancing the management of ADHD across the lifespan
- Congress reports
- Key congresses 2021
- On-demand events
- Publications
- Takeda in ADHD
- Contact us
- Terms of use
- Privacy notice
- Register
- Search
- Sitemap
Posts by category
- Category: Publications 2019
- Viewpoint: should the ADHD diagnostic criteria be revised?
- What do clinicians involved in transitioning adolescents with ADHD from child to adult services think about the recommendations from the NICE guidelines?
- Clinical practice and opinions of adult ADHD in Germany
- Prediction of current and retrospective symptoms of ADHD in adolescence and adulthood using virtual reality
- Practical considerations for adult ADHD: a French perspective
- How does a diagnosis of ADHD affect children with hyperactivity/inattention symptoms?
- Developmental and environmental factors in adolescence may contribute to symptoms of late-onset ADHD
- The effect of long-term stimulant medication on growth trajectories in children with ADHD: results from the MTA study
- Use of two surveillance methods to estimate the need for transition between child and adult mental health services in young people with ADHD in the UK
- Waiting times from referral to ADHD diagnosis for children and adolescents in Italy
- Public perception of ADHD in children and adults: a German population study
- A methodological approach to mapping adult ADHD services in the UK
- Are there cross-country differences in parental reporting of ADHD symptoms?
- Results from the MTA study: is there a link between depression and ADHD-related risk for substance use in adolescence and early adulthood?
- “I’ve got a text!” Use of a novel text messaging intervention in adults with ADHD to improve adherence to stimulants
- The efficacy of non-pharmacological interventions on internalising symptoms associated with ADHD
- Exploring the impact of ADHD on the daily lives of adults currently taking ADHD medication
- Adherence to stimulant medication in children and adolescents with ADHD
- Recommendations by the European ADHD Guidelines Group for pharmacotherapy research on ADHD
- Examining the transition from child to adult support services for young people with ADHD in the UK and Republic of Ireland
- Predictors of ADHD persistence: a 9-year follow-up study
- Impact of ADHD on athletes and the effects of sport participation on ADHD
- The impact of ADHD in elite athletes
- Exposure to the natural environment, rurality and children with ADHD in New Zealand
- Identification of an ocular biomarker for children with ADHD?
- Guidelines for the development of technological interventions for the self-management of ADHD in children and adolescents
- An investigation into the resumption of ADHD medication in early adulthood in UK primary care
- The effects of a sibling-mediated intervention on social skills in young children with ADHD
- How accurate is self-reported recall of childhood symptoms of ADHD?
- Adolescent ADHD and smartphone addiction: development and validation of a parental management scale
- Category: Publications 2020
- Social and economic costs of ADHD
- Neurocognitive markers of late-onset ADHD in children and adolescents
- Is there an association between creativity and ADHD?
- Difficulties with remote learning for adolescents with ADHD during COVID-19
- A review of various biomarkers, risk factors and protective factors for ADHD
- ADHD and the risk of changes in perceived peer and personal alcohol use during young adulthood
- Levels of branched chain amino acids in maternal and cord plasma and child risk of ADHD: a prospective birth cohort study
- Assessment of methods to evaluate emotional dysregulation in adolescents
- Are there sex differences in ADHD pharmacotherapy?
- Context regulation of mind wandering in adult ADHD
- ADHD drug prescriptions in Germany
- Identification and treatment of ADHD in girls and women: a consensus statement
- Technology-based interventions for ADHD: a review
- Children with ADHD grown up: an 18-year follow-up study
- Prevalence of ADHD in older adults aged ≥50 years
- Finding answers to treatment dilemmas in ADHD
- Link between ADHD and eating disorders: does ADHD impact treatment outcome and adherence?
- Screening, diagnosis and treatment of adolescents with ADHD and substance-use disorder: an International Consensus Statement
- New algorithm for identifying ADHD in primary care in Canada
- ADHD and risk for COVID-19 infection
- Use of direct-to-consumer telemedicine for ADHD
- ADHD in the transition to adulthood: a German perspective
- Impact of childhood ADHD on the health and well-being of parents
- A future psychiatrist’s personal experience of ADHD
- Is there an association between ADHD and entrepreneurship?
- Culturally responsive approaches for addressing ADHD
- The neuroscience of ADHD and ASD: the ENIGMA adventure
- ADHD and COVID-19: challenges and opportunities for management in Ireland
- Low treatment rates of young adults with ADHD across the UK
- Starting ADHD medications during the COVID-19 pandemic
- ADHD in adults aged ≥50 years: being different but striving to seem normal
- Children with ADHD and friendship quality
- ‘Lifestyles of the rich and famous’ with ADHD
- The risk for affective temperament, hypomania and suicide in adults with ADHD
- How can ADHD be managed during the COVID-19 pandemic?
- Stakeholder perspectives of ADHD awareness in primary care
- Healthcare utilisation trajectories and the economic impact of comorbidities in young adults with childhood ADHD
- The impact of ADHD in criminal law
- Do early ADHD symptoms predict eating behaviours in later childhood?
- Reciprocal developmental relationship between ADHD and anxiety during adolescence
- Does cannabis use affect the cognitive performance and symptoms of ADHD in adults?
- What differentiates children with ADHD symptoms who do and do not receive a formal diagnosis?
- How are children with ADHD managed in primary care as they mature through adolescence?
- “I’ve got a text!” – use of a novel text-messaging intervention in children with ADHD to improve adherence to stimulants
- Does treatment duration affect the efficacy of pharmacological treatments for ADHD?
- Childhood predictors of de novo and subthreshold late-onset ADHD
- Optimising transition of care for young people with ADHD
- A review of ADHD in light of scientific advances
- What have we learned about the management of childhood ADHD 20 years after the initiation of the MTA study?
- Unmet care needs of children and adolescents with ADHD in specialised mental health care settings in the Netherlands
- Category: Publications 2021
- How have COVID-19 restrictions affected functioning of children and adolescents with ADHD?
- Substance use in adults with ADHD: practice guidelines
- The prevalence of ADHD and adult bipolar disorder comorbidity
- Improving transitional support for ADHD from childhood to adulthood in France
- Next steps for future research for diagnosing ADHD in older adults
